Randomized Trial of Alternative Quadrivalent Human Papilloma Virus (HPV) Vaccination Schedules in a University Setting

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

April 30, 2009

Study Completion Date

August 31, 2009

Conditions
Human Papillomavirus Infection
Interventions
BIOLOGICAL

Quadrivalent human papillomavirus vaccine on-time administration

The vaccine is given in three doses: Dose 1; dose 2 given 60 days later; dose 3 given six months after dose 1.

BIOLOGICAL

Quadrivalent human papillomavirus vaccine delayed administration

The vaccine is given in three doses: Dose 1; dose 2 given 60 days later; dose 3 given 12 months after dose 1.

Trial Locations (1)

15213

University of Pittsburgh, Pittsburgh

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

University of Pittsburgh

OTHER

NCT00572832 - Randomized Trial of Alternative Quadrivalent Human Papilloma Virus (HPV) Vaccination Schedules in a University Setting | Biotech Hunter | Biotech Hunter